GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Portage Biotech Inc (NAS:PRTG) » Definitions » Shiller PE Ratio

Portage Biotech (Portage Biotech) Shiller PE Ratio : 0.06 (As of May. 12, 2024)


View and export this data going back to . Start your Free Trial

What is Portage Biotech Shiller PE Ratio?

As of today (2024-05-12), Portage Biotech's current share price is $0.2523. Portage Biotech's E10 for the quarter that ended in Dec. 2023 was $4.57. Portage Biotech's Shiller PE Ratio for today is 0.06.

The historical rank and industry rank for Portage Biotech's Shiller PE Ratio or its related term are showing as below:

PRTG' s Shiller PE Ratio Range Over the Past 10 Years
Min: 0   Med: 0   Max: 9.39
Current: 0.06

During the past years, Portage Biotech's highest Shiller PE Ratio was 9.39. The lowest was 0.00. And the median was 0.00.

PRTG's Shiller PE Ratio is ranked better than
99.34% of 151 companies
in the Biotechnology industry
Industry Median: 35.93 vs PRTG: 0.06

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Portage Biotech's adjusted earnings per share data for the three months ended in Dec. 2023 was $-1.880. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $4.57 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Portage Biotech Shiller PE Ratio Historical Data

The historical data trend for Portage Biotech's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Portage Biotech Shiller PE Ratio Chart

Portage Biotech Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.32 2.73 7.14 1.45 0.70

Portage Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.09 0.70 0.74 0.44 0.40

Competitive Comparison of Portage Biotech's Shiller PE Ratio

For the Biotechnology subindustry, Portage Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Portage Biotech's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Portage Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Portage Biotech's Shiller PE Ratio falls into.



Portage Biotech Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Portage Biotech's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=0.2523/4.57
=0.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Portage Biotech's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Portage Biotech's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-1.88/129.4194*129.4194
=-1.880

Current CPI (Dec. 2023) = 129.4194.

Portage Biotech Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -1.000 99.695 -1.298
201406 -0.435 100.560 -0.560
201409 -0.401 100.428 -0.517
201412 -0.310 99.070 -0.405
201503 -1.000 99.621 -1.299
201506 -0.360 100.684 -0.463
201509 -0.414 100.392 -0.534
201512 -1.000 99.792 -1.297
201603 0.000 100.470 0.000
201606 -1.000 101.688 -1.273
201609 13.000 101.861 16.517
201612 -2.000 101.863 -2.541
201703 -4.000 102.862 -5.033
201706 -0.127 103.349 -0.159
201709 -0.129 104.136 -0.160
201712 -0.133 104.011 -0.165
201803 46.279 105.290 56.885
201806 -0.078 106.317 -0.095
201809 -0.074 106.507 -0.090
201812 -0.109 105.998 -0.133
201903 -0.177 107.251 -0.214
201906 -0.130 108.070 -0.156
201909 -0.120 108.329 -0.143
201912 -0.120 108.420 -0.143
202003 -0.120 108.902 -0.143
202006 -0.060 108.767 -0.071
202009 -0.210 109.815 -0.247
202012 -0.100 109.897 -0.118
202103 -0.980 111.754 -1.135
202106 -0.250 114.631 -0.282
202109 -0.220 115.734 -0.246
202112 -0.260 117.630 -0.286
202203 -0.550 121.301 -0.587
202206 -0.130 125.017 -0.135
202209 -0.060 125.227 -0.062
202212 -0.440 125.222 -0.455
202303 -5.840 127.348 -5.935
202306 -0.330 128.729 -0.332
202309 -0.290 129.860 -0.289
202312 -1.880 129.419 -1.880

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Portage Biotech  (NAS:PRTG) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Portage Biotech Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Portage Biotech's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Portage Biotech (Portage Biotech) Business Description

Traded in Other Exchanges
N/A
Address
Clarence Thomas Building, P.O. Box 4649, Tortola, Road Town, VGB, VG1110
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through to clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.

Portage Biotech (Portage Biotech) Headlines

From GuruFocus